Cost-effectiveness of the introduction of a pre-erythrocytic malaria vaccine into the expanded program on immunization in sub-Saharan Africa: Analysis of uncertainties using a stochastic individual-based simulation model of Plasmodium falciparum malaria

Value in Health

Volumn 14, Issue 8, 2011, Pages 1028-1038

  Maire, Nicolas ^a,b   Shillcutt, Samuel D ^c   Walker, Damian G ^c,d   Tediosi, Fabrizio ^e   Smith, Thomas A ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d BILL AND MELINDA GATES FOUNDATION   (United States)

^e BOCCONI UNIVERSITY   (Italy)

Author keywords

cost effectiveness; expected value of perfect information; malaria; probabilistic sensitivity analysis; vaccine

Indexed keywords

MALARIA VACCINE;

AFRICA; ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DISABILITY ADJUSTED LIFE YEAR; DRUG COST; ENDEMIC DISEASE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; IMMUNIZATION; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; QUALITY OF LIFE INDEX; SIMULATION; STOCHASTIC MODEL;

AFRICA SOUTH OF THE SAHARA; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; HUMANS; IMMUNIZATION PROGRAMS; MALARIA VACCINES; MALARIA, FALCIPARUM; MODELS, THEORETICAL; PLASMODIUM FALCIPARUM; STOCHASTIC PROCESSES;

EID: 82955168393     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2011.06.004     Document Type: Article

References (77)

1. W.R. Ballou The development of the RTS,S malaria vaccine candidate: challenges and lessons Parasite Immunol 31 2009 492 500
2. N. Maire, J.J. Aponte, A. Ross Modeling a field trial of the RTS,S/AS02A malaria vaccine Am J Trop Med Hyg 75 2006 104 110
3. R.W. Snow, C.A. Guerra, A.M. Noor The global distribution of clinical episodes of Plasmodium falciparum malaria Nature 434 2005 214 217 (Pubitemid 40388051)
4. N. Maire, F. Tediosi, A. Ross, T. Smith Predictions of the epidemiologic impact of introducing a pre-erythrocytic vaccine into the expanded program on immunization in sub-Saharan Africa Am J Trop Med Hyg 75 2006 111 118
5. M.A. Penny, N. Maire, A. Studer What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines PLoS ONE 3 2008 e3193
6. J.T. Griffin, T.D. Hollingsworth, L.C. Okell Reducing plasmodium falciparum malaria transmission in Africa: A model-based evaluation of intervention strategies PLoS Med 7 2010 e1000324
7. F. Tediosi, G. Hutton, N. Maire Predicting the cost-effectiveness of introducing a pre-erythrocytic malaria vaccine into the expanded program on immunization in Tanzania Am J Trop Med Hyg 75 2006 131 143
8. F. Tediosi, N. Maire, M. Penny Simulation of the cost-effectiveness of malaria vaccines Malar J 8 2009 127
9. J.C. Felli, G.B. Hazen Sensitivity analysis and the expected value of perfect information Med Decis Making 18 1998 95 109 (Pubitemid 28041646)
10. E. de Gourville, R.J. Duintjer Tebbens Global surveillance and the value of information: the case of the global polio laboratory network Risk Anal 26 2006 1557 1569 (Pubitemid 44952475)
11. N. Maire, T. Smith, A. Ross A model for natural immunity to asexual blood stages of Plasmodium falciparum malaria in endemic areas Am J Trop Med Hyg 75 2006 19 31
12. A. Ross, N. Maire, L. Molineaux, T. Smith An epidemiologic model of severe morbidity and mortality caused by Plasmodium falciparum Am J Trop Med Hyg 75 2006 63 73
13. T. Smith, A. Ross, N. Maire An epidemiologic model of the incidence of acute illness in Plasmodium falciparum malaria Am J Trop Med Hyg 75 2 Suppl. 2006 56 62
14. T. Smith, N. Maire, K. Dietz Relationship between the entomologic inoculation rate and the force of infection for Plasmodium falciparum malaria Am J Trop Med Hyg 75 2006 11 18
15. A. Ross, G.F. Killeen, T. Smith Relationships of host infectivity to mosquitoes and asexual parasite density in Plasmodium falciparum Am J Trop Med Hyg 75 2 Suppl. 2006 32 37
16. T. Smith, G.F. Killeen, N. Maire Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: Overview Am J Trop Med Hyg 75 2006 1 10
17. INDEPTH Network: Population, Health and Survival at INDEPTH Sites 2002 IDRC Ottawa
18. T. Smith, N. Maire, A. Ross Towards a comprehensive simulation model of malaria epidemiology and control Parasitology 135 2008 1507 1516
19. F. Tediosi, N. Maire, T. Smith An approach to model the costs and effects of case management of Plasmodium falciparum malaria in sub-Saharan Africa Am J Trop Med Hyg 75 2006 90 103
20. C.J.L. Murray, A.D. Lopez The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020 1996 Harvard University Press Cambridge, MA
21. C.D. Mathers, A.D. Lopez, C.J.L. Murray The burden of disease and mortality by condition: Data, Methods, and Results for 2001 A. Lopez, C. Mathers, M. Ezzati, D. Jamison, C.J.L. Murray, Global Burden of Disease and Risk Factors 2006 Oxford University Press New York
22. World Health Organisation WHO-CHOICE CHOosing Interventions That Are Cost-Effective 2008 World Health Organisation Geneva http://www.who.int/choice/ en/ [Accessed January 1, 2010]
23. A. Bosman, K.N. Mendis A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies Am J Trop Med Hyg 77 2007 193 197
24. C.A. Goodman, P.G. Coleman, A. Mills Economic Analysis of Malaria Control in Sub-Saharan Africa 2000 Global Forum for Health Research Geneva
25. S.I. Hay, C.A. Guerra, P.W. Gething A world malaria map: Plasmodium falciparum endemicity in 2007 PLoS Med 6 2009 e1000048
26. A.J. Tatem, D.L. Smith, P.W. Gething Ranking of elimination feasibility between malaria-endemic countries Lancet 376 2010 1579 1591
27. D.J. Spiegelhalter, A. Thomas, N. Best, D. Lunn Winbugs Version 1.4 2003 MRC-BSU Cambridge, UK
28. D.L. Smith, J. Dushoff, R.W. Snow, S.I. Hay The entomological inoculation rate and Plasmodium falciparum infection in African children Nature 438 2005 492 495 (Pubitemid 41742019)
29. Oak Ridge National Laboratory LandScanTM Global Population Database 2010 Oak Ridge National Laboratory Oak Ridge TN
30. B.A. van Hout, M.J. Al, G.S. Gordon, F.F. Rutten Costs, effects and C/E-ratios alongside a clinical trial Health Econ 3 1994 309 319
31. T. Tan-Torres Edejer, R. Baltussen, T. Adam Making Choices in Health: WHO Guide to Cost-effectiveness Analysis 2003 World Health Organisation Geneva
32. A.H. Briggs, D.E. Wonderling, C.Z. Mooney Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation Health Econ 6 1997 327 340 (Pubitemid 27384638)
33. C.A. Goodman The Economic Evaluation of Malaria Diagnosis 1999 World Health Organisation and USAID Geneva
34. M. Amexo, R. Tolhurst, G. Barnish, I. Bates Malaria misdiagnosis: effects on the poor and vulnerable Lancet 364 2004 1896 1898 (Pubitemid 39536094)
35. H. Reyburn, J. Ruanda, O. Mwerinde, C. Drakeley The contribution of microscopy to targeting antimalarial treatment in a low transmission area of Tanzania Malar J 5 2006 4
36. P. Magnussen, B. Ndawi, A.K. Sheshe Malaria diagnosis and treatment administered by teachers in primary schools in Tanzania Trop Med Int Health 6 2001 273 279 (Pubitemid 32385853)
37. World Health Organisation Sources and Prices of Selected Products for the Prevention, Diagnosis, and Treatment of Malaria 2004 WHO/RBM/UNICEF/PSI/MSH Geneva
38. S.P. Kachur, R.A. Khatib, E. Kaizer Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania Am J Trop Med Hyg 71 2004 715 722 (Pubitemid 40075619)
39. C. Fogg, F. Bajunirwe, P. Piola Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda Am J Trop Med Hyg 71 2004 525 530 (Pubitemid 39601144)
40. E. Depoortere, E.T. Salvador, E. Stivanello Adherence to a combination of artemether and lumefantrine (Coartem) in Kajo Keji, southern Sudan Ann Trop Med Parasitol 98 2004 635 637 (Pubitemid 39215518)
41. I.O. Ajayi, E.N. Browne, B. Garshong Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites Malar J 7 2008 6
42. A.A. Stinnett, J. Mullahy Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis Med Decis Making 18 Suppl. 1998 S68 S80
43. W.P. O'Meara, J.N. Mangeni, R. Steketee, B. Greenwood Changes in the burden of malaria in sub-Saharan Africa Lancet Infect Dis 10 2010 545 555
44. World Health Organisation World Malaria Report 2008 2008 World Health Organisation Geneva
45. J.A. Omumbo, C.A. Guerra, S.I. Hay, R.W. Snow The influence of urbanisation on measures of Plasmodium falciparum infection prevalence in East Africa Acta Trop 93 2005 11 21 (Pubitemid 39611350)
46. J. Keiser, J. Utzinger, M.C. De Castro Urbanization in sub-Saharan Africa and implication for malaria control Am J Trop Med Hyg 71 2004 118 127 (Pubitemid 39121312)
47. D. Jima, A. Getachew, H. Bilak Malaria indicator survey 2007, Ethiopia: coverage and use of major malaria prevention and control interventions Malar J 9 2010 58
48. L. Gosoniu, A.M. Veta, P. Vounatsou Bayesian geostatistical modeling of Malaria Indicator Survey data in Angola PLoS ONE 5 2010 e9322
49. C. Drakeley, P. Corran, P. Coleman Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure Proc Natl Acad Sci USA 102 2005 5108 5113
50. World Health Organisation Current Malaria Situation and Trends 2007 World Health Organisation, Regional Office for South East Asia New Delhi
51. B. Robberstad, J. Cairns Time preferences for health in northern Tanzania: an empirical analysis of alternative discounting models Pharmacoeconomics 25 2007 73 88 (Pubitemid 46072369)
52. M. Grabowsky The billion-dollar malaria moment Nature 451 2008 1051 1052 (Pubitemid 351317432)
53. C.J. Murray, B. Shengelia, N. Gupta Validity of reported vaccination coverage in 45 countries Lancet 362 2003 1022 1027 (Pubitemid 37186879)
54. C. Barker, A. Green Opening the debate on DALYs (disability-adjusted life years) Health Policy Plan 11 1996 179 183
55. S. Anand, K. Hanson Disability-adjusted life years: a critical review J Health Econ 16 1997 685 702 (Pubitemid 28046571)
56. Disease Control Priorities in Developing Countries 2nd ed. 2006 The World Bank and Oxford University Press Washington, DC
57. Global Burden of Disease and Risk Factors 2006 The World Bank and Oxford University Press Washington, DC
58. D. de Savigny, T. Adam Alliance for Health Policy and Systems Research Systems Thinking for Health Systems Strengthening 2009 World Health Organisation Geneva
59. P. Musgrove Public spending on health care: how are different criteria related? Health Policy 47 1999 207 223 (Pubitemid 29253826)
60. K. Claxton Decision making, uncertainty, and the value of information A. Briggs, K. Claxton, M. Sculpher, Decision Modelling for Health Economic Evaluation 2006 Oxford University Press Oxford, UK
61. Global Fund to fight Aids Tuberculosis and Malaria, 2004 Grant Report: Prompt and Effective Treatment of Malaria Cases and Detection and Containment of Malaria Epidemics http://portfolio.theglobalfund.org/en/Grant/Index/TNZ-405- G08-M [Accessed July 12, 2011]
62. Health Research for Action Health Care Financing in Tanzania: Costing Study of Health Services Final Report Volume 1 1999 Health Research for Action Laarstraat, Belgium
63. L. Gilson Health economics exchange World Health Forum 13 1992 202
64. M. Adjuik, A. Babiker, P. Garner Artesunate combinations for treatment of malaria: meta-analysis Lancet 363 2004 9 17 (Pubitemid 38076919)
65. G. Lefevre, S. Looareesuwan, S. Treeprasertsuk A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand Am J Trop Med Hyg 64 2001 247 256
66. C. Goodman, P. Coleman, A. Mills Economic Analysis of Malaria Control in Sub-Saharan Africa 2000 Global Forum for Health Research Geneva
67. D.R. Brewster, D. Kwiatkowski, N.J. White Neurological sequelae of celebral malaria in children Lancet 336 1990 1039 1043 (Pubitemid 20366354)
68. G.M. Mwabu Health care decisions at the household level: results of a rural health survey in Kenya Soc Sci Med 22 1986 315 319 (Pubitemid 16125461)
69. D. Ongore, F. Kamunvi, R. Knight, A. Minawa A study of knowledge, attitudes and practices (KAP) of a rural community on malaria and the mosquito vector East Afr Med J 66 1989 79 90 (Pubitemid 20430241)
70. S.C. McCombie Treatment seeking for malaria: a review of recent research Soc Sci Med 43 1996 933 945
71. A.E. Greenberg, M. Ntumbanzondo, N. Ntula Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire Bull World Health Organ 67 1989 189 196 (Pubitemid 19160708)
72. E. Nelson, M. Weikert, J.A. Phillips Paediatric treatment costs and the HIV epidemic Cent Afr J Med 41 1995 139 144
73. A. Faye Management of children infected by human immunodeficiency virus and of the family in the frame work of humanitarian mission in Tanzania Arch Pediatr 3 Suppl. 1 1996 27s 31s (Pubitemid 26178581)
74. T. Adam, C. Kakundwa, F. Manzi Analysis Report on the Costs of IMCI in Tanzania Multi-Country Evaluation of the Integrated Management of Childhood Illness (IMCI), World Health Organisation 2004 Department of Child and Adolescent Health and Development, World Health Organisation Geneva
75. C.A. Goodman, A.J. Mills The evidence base on the cost-effectiveness of malaria control measures in Africa Health Policy Plan 14 1999 301 312
76. M. Alonso-Gonzalez, C. Menendez, F. Font Cost-effectiveness of iron supplementation and malaria chemoprophylaxis in the prevention of anaemia and malaria among Tanzanian infants Bull World Health Organ 78 2000 97 107 (Pubitemid 30094231)
77. G. Hutton, F. Tediosi The costs of introducing a malaria vaccine through the expanded program on immunization in Tanzania Am J Trop Med Hyg 75 2006 119 130